A Study of Probiotics in Patients With Acute Ischemic Stroke

Starting soon · Phase 2 · Has a placebo group

Conditions studied: Ischemic Stroke

In brief

The primary objective of this study is to evaluate the effect of daily oral administration of the probiotic supplement OMNi-BiOTiC® SR-9 for 90 days, compared to placebo, on gut microbiome beta diversity in patients aged 60 years or older with acute ischemic stroke.

Key facts

Study ID
NCT07651332
Run by
Capital Medical University
People needed
220
Starts
2026-09-01
Expected to finish
2027-12-31
Last updated by the study team
2026-06-17

Who can join

Age: 60 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.